Oxidation time effect of activated carbons for drug adsorption
Keywords: Activated carbon; Oxidation time; Adsorption; Drug; Pramipexole; Characterization
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Environmental friendly technology for the removal of pharmaceutical contaminants from wastewaters using modified chitosan adsorbents
Keywords: Chitosan; Environmental friendly adsorbent; Grafting; Modeling; Pharmaceutical wastewaters; Pramipexole
Anhedonia in Japanese patients with Parkinson's disease: Analysis using the Snaith–Hamilton Pleasure Scale
Keywords: Snaith–Hamilton Pleasure Scale (SHAPS); Anhedonia; Parkinson's disease; Pramipexole
The role of the dopaminergic system in mood, motivation and cognition in Parkinson's disease: A double blind randomized placebo-controlled experimental challenge with pramipexole and methylphenidate
Keywords: Mood; Motivation; Cognition; Parkinson; Methylphenidate; Pramipexole; Dopamine;
Efficacy and safety of pramipexole in chinese patients with restless legs syndrome: Results from a multi-center, randomized, double-blind, placebo-controlled trial
Keywords: Pramipexole; Restless legs syndrome; Clinical trial; Dopamine agonist; Multi-center randomized trial; Placebo-controlled trial
Long-term use of pramipexole in the management of restless legs syndrome
Keywords: Restless legs syndrome; RLS; Willis–Ekbom disease; Pramipexole; Augmentation; Dopaminergic; Impulse control disorder
Effect of pramipexole on cutaneous-silent-period parameters in patients with restless legs syndrome
Keywords: Cutaneous silent period; Restless legs syndrome; Pramipexole
The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease
Keywords: Dopamine agonists; Heart failure; Parkinson disease; Pramipexole
Stereochemical and neuroanatomical selectivity of pramipexole effects on sensorimotor gating in rats
Keywords: Dopamine receptor; Islands of Calleja; Nucleus accumbens; Pramipexole; Prepulse inhibition; Stereoisomer
Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls
Keywords: Conditioned place preference; Pramipexole; Methamphetamine; 6-OHDA; Reward; Motor
Pramipexole is active in depression tests and modulates monoaminergic transmission, but not brain levels of BDNF in mice
Keywords: BDNF; Depression; Dopamine; Mouse; Monoamines; Pramipexole; 5-HT
The abolishment of anesthesia-induced cognitive impairment by timely protection of mitochondria in the developing rat brain: The importance of free oxygen radicals and mitochondrial integrity
Keywords: GA; general anesthesia; ROS; reactive oxygen species; EUK-134; chloro[[2,2â²-[1,2-ethanediylbis[(nitrilo-κN)methylidyne]]bis[6-methoxyphenolato-κO]]]-manganese; PPX; pramipexole; CA1; Cornu Ammonis area 1; DNA; deoxyribonucleic acid; Mn-SOD; manganese-
Evaluation of painful sensory symptoms in restless legs syndrome: Experience from two clinical trials
Keywords: Restless legs syndrome; Pain; Outcome; Pramipexole; Treatment; Randomized controlled trial
Disparate effects of pramipexole on locomotor activity and sensorimotor gating in Sprague-Dawley rats
Keywords: Dopamine; Locomotor activity; Pramipexole; Prepulse inhibition; Startle;
A 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndrome
Keywords: Restless legs syndrome; Restless legs augmentation; Long-term follow-up; Methadone; Pramipexole; Pergolide; Dopamine agonist; Opioid
Dopaminergic drug-induced modulation of the expression of the dopamine transporter in peripheral blood lymphocytes in Parkinson’s disease
Keywords: dopamine transporter; levodopa; Parkinson’s disease; peripheral blood lymphocytes; pramipexole; ropinirole
The long-term effects of the dopamine agonist pramipexole in a proposed restless legs syndrome animal model
Keywords: Restless legs syndrome; Augmentation; Animal model; Pramipexole; Dopamine agonist; Dopamine receptors; Iron;
Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood
Keywords: Controlled clinical trials, randomized; Restless legs syndrome; Pramipexole; Movement disorders; Depression; Mood disturbance;
Dopamine D2-like receptor agonists induce penile erection in male rats: differential role of D2, D3 and D4 receptors in the paraventricular nucleus of the hypothalamus
Keywords: Dopamine agonists; Pramipexole; Apomorphine; PD 168,077; Penile erection; Paraventricular nucleus of the hypothalamus; Rat;
Response Perseveration in Stimulant Dependence Is Associated with Striatal Dysfunction and Can Be Ameliorated by a D2/3 Receptor Agonist
Keywords: Dopamine; fMRI; obsessive-compulsive disorder; pramipexole; probabilistic reversal learning; substance dependence
Efficacy and augmentation during 6 months of double-blind pramipexole for restless legs syndrome
Keywords: Restless legs syndrome; Pramipexole; Dopamine agonists; Augmentation; Therapy; Long-term treatment; Withdrawal
Stability studies and structural characterization of pramipexole
Keywords: Pramipexole; IR; X-ray diffraction; NMR; Thermal analysis
Long-term open-label study of pramipexole in patients with primary restless legs syndrome
Keywords: Augmentation; Japanese patients; Nonergot dopamine agonist; Phase III long-term clinical study; Pramipexole; Restless legs syndrome
Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study
Keywords: Restless legs syndrome (RLS); The International Restless Legs Syndrome Study Group rating scale (IRLS); Pittsburgh Sleep Quality Index (PSQI); Periodic limb movements (PLM); Suggested immobilization test (SIT); Pramipexole; Epworth sleepiness scale (ESS)
An anti-Parkinson drug ropinirole depletes orexin from rat hypothalamic slice culture
Keywords: Hypocretin; Melanin-concentrating hormone; Sleep attack; Ropinirole; Talipexole; Pramipexole; c-Fos;
Toxicity assessment of pramipexole in juvenile rhesus monkeys
Keywords: PPX; pramipexole; DA; dopamine; PD; Parkinson's disease; RLS; restless leg syndrome; NCTR; National Center for Toxicological Research; OTB; operant test battery; DIUF; deionized ultra-filtered; MGSS; Multi-Generation Support System; GFAP; glial fibrillary
Dual motor response to l-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D2/D3 receptor blockade
Keywords: Dopamine; MPTP; l-dopa; Pramipexole; Nociceptin/orphanin FQ; Trap-101; J-113397
From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease
Keywords: Ropinirole; Pramipexole; Pergolide; Antiparkinson; α2-Adrenoceptor; D2 receptor; D3 receptor; ACh; acetylcholine; Akt; atypical kinase; AR; adrenoceptor; BDNF; brain derived neurotrophic factor; COMT; catechol-Ortho-methyltransferase; DA; dopamine; ERK;
Increased Frequency and Range of Sexual Behavior in a Patient with Parkinson's Disease After Use of Pramipexole: A Case Report
Keywords: Parkinson's Disease; Hypersexuality; Dopamine Agonist; Pramipexole; Anal Intercourse;
New considerations in the medical management of early Parkinson's disease: Impact of recent clinical trials on treatment strategy
Keywords: Parkinson's disease; Treatment; Selegiline; Rasagiline; Pramipexole; Ropinirole; Levodopa
Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats
Keywords: Pramipexole; Depression; Olfactory bulbectomy; Dopamine; Antidepressant; (Rat)
Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice
Keywords: Parkinson's disease; Rotenone; Pramipexole; DJ-1; α-Synuclein
Dopamine receptor activation promotes adult neurogenesis in an acute Parkinson model
Keywords: Adult neurogenesis; Neural progenitor cells; Dopamine; Parkinson; Dopamine agonist; Pramipexole
Open-label study of the long-term efficacy and safety of pramipexole in patients with Restless Legs Syndrome (extension of the PRELUDE study)
Keywords: Restless Legs Syndrome; Long-term efficacy; Pramipexole; RLS; ESS; CGI-I; PGI-I; SF-36
Effect of pramipexole on RLS symptoms and sleep: A randomized, double-blind, placebo-controlled trial
Keywords: Pramipexole; Sleep; Restless Legs Syndrome; Randomized controlled trial; Dopamine D1/D2 agonists; Medical Outcomes Study Sleep Measure
Cabergoline and pramipexole fail to modify already established dyskinesias in an animal model of parkinsonism
Keywords: Parkinson's disease; Dopamine agonists; Cabergoline; Pramipexole; Levodopa; Levodopa-induced dyskinesias; 6-OHDA-lesioned rat
Regulation of intracellular dopamine levels by dopaminergic drugs: Involvement of vesicular monoamine transporter
Keywords: Dopamine; Dopaminergic drug; Parkinson disease; Pramipexole; VMAT;
Continuous subcutaneous infusion of pramipexole protects against lipopolysaccharide-induced dopaminergic cell death without affecting the inflammatory response
Keywords: Lipopolysaccharide; Pramipexole; Substantia nigra; Striatum; Inducible nitric oxide synthase (iNOS); Glial cells; Parkinson's disease
Chitosan nanoparticles loaded with dorzolamide and pramipexole
Keywords: Chitosan; Nanoparticles; Ionotropic gelation; Pramipexole; Dorzolamide
Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome
Keywords: Restless legs syndrome; Meta-analysis; Pramipexole; Non-ergot dopamine agonists; Efficacy; Safety
First night efficacy of pramipexole in restless legs syndrome and periodic leg movements
Keywords: Restless legs syndrome; Periodic leg movements; Pramipexole; Sleep; Dopamine; On-demand Therapy
A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease
Keywords: Parkinson's disease; Cognition; Dopamine agonists; Pramipexole; Levodopa; Executive function
Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease
Keywords: Anhedonia; Depression; Parkinson's disease; Dopamine agonist; Pramipexole
Use of pramipexole in REM sleep behavior disorder: Results from a case series
Keywords: REM behavior disorder; Pramipexole; Dopaminergic; Clonazepam; Restless leg syndrome; Periodic limb movements in sleep
Efficacy and safety of pramipexole in idiopathic restless legs syndrome: A polysomnographic dose-finding study—The PRELUDE study
Keywords: Restless legs syndrome; RLS; Periodic limb movements; Sleep; Polysomnography; Pramipexole; Placebo-controlled
Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study
Keywords: Parkinson's disease; Excessive daytime somnolence; Sleep episodes; Polysomnography; Cabergoline; Pramipexole; l-Dopa;